Clinical Trial Update: Efficacy and Safety of Lenalidomide in Combination With Cyclosporine A in Patients With Myelodysplastic Syndromes [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lenalidomide with cyclosporine A in patients with myelodysplastic syndromes; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• Cyclosporine A (cyclosporine)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Myelodysplastic Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2019-11-19